98%
921
2 minutes
20
Introduction: Publishing medical metadata stored in case report forms (CRFs) is a prerequisite for the development of a learning health system (LHS) by fostering reuse of metadata and standardization in health research. The aim of our study was to investigate medical researchers' (MRs) willingness to share CRFs, to identify reasons for and against CRF sharing, and to determine if and under which conditions MRs might consider sharing CRF metadata via a public registry.
Methods: We examined CRF data sharing commitments for 1842 interventional trials registered on the German Clinical Trials Registry (DRKS) from January 1, 2020, to December 31, 2021. We invited 1360 individuals registered as contacts on DRKS to participate in a web-based survey between May 10, 2022, and June 30, 2022.
Results: Only 0.3% (5/1842) of data sharing commitments in DRKS included a plan to share blank CRFs. Survey results showed high support for CRF sharing. More than 70% of respondents (223/301) were willing to share their CRFs, and 83.7% (252/301) were interested in CRF reuse. The most frequently reported reason for CRF sharing was improvement of comparability and interpretability of patient data (244/301; 81.0%). The most frequently reported reason against CRF sharing was missing approval by the sponsor (160/301; 53.2%). Researchers conducting commercial trials were significantly less likely to share CRFs than those conducting noncommercial trials (63.3% vs. 76.2%, OR 0.54, 95% CI 0.32-0.92) and they were less likely to reuse CRFs (78.5% vs. 84.6%, OR 0.66, 95% CI 0.35-1.24). The most frequently mentioned prerequisite for publication of CRFs in a public registry was its trustworthiness (244/301, 81.1%).
Conclusion: Data sharing commitments in DRKS revealed a low awareness of CRF sharing. Survey results showed generally strong support for CRF sharing, including the willingness to publish CRFs in a public registry, although legal and practical barriers were identified.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733469 | PMC |
http://dx.doi.org/10.1002/lrh2.10456 | DOI Listing |
Alzheimers Dement (N Y)
August 2025
Introduction: Although hallmarked by β-amyloid plaques (Aβ) and neurofibrillary tangles (tau), Alzheimer's disease (AD) is a multifactorial disorder that involves neuroinflammation, neurodegeneration, and synaptic dysfunction. AD-associated biomolecular changes seem to be attenuated in carriers of the functionally advantageous variant of the gene (KL-VS). Independently, better cardiorespiratory fitness (CRF) is associated with better health outcomes related to AD pathology.
View Article and Find Full Text PDFTheranostics
August 2025
MediCity Research Laboratory and InFLAMES Flagship, University of Turku, Turku, Finland.
Clever-1 is a multifunctional scavenger receptor that promotes immunosuppressive activity in macrophages, contributing to tumor immune evasion. Its high expression correlates with resistance to immune checkpoint inhibitors, and co-targeting Clever-1 with anti-PD-1 enhances therapeutic efficacy in refractory tumor models. The humanized anti-Clever-1 IgG4 antibody, bexmarilimab, is under clinical investigation for treating solid tumors (NCT03733990) and hematological malignancies (NCT05428969).
View Article and Find Full Text PDFJ Gen Intern Med
July 2025
Geriatric Research Educational and Clinical Center (GRECC) and the VETWISE-LHS Center of Innovation, VA Tennessee Valley Healthcare System, Nashville, TN, USA.
Background: Lung cancer screening program navigators improve adherence and patient experience. However, little is known about how navigators improve program outcomes.
Objective: The aim of this qualitative study was to explore factors influencing the lung cancer screening program navigator role.
Asia Pac J Ophthalmol (Phila)
July 2025
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, China; Department of Ophthalmology and Visual Sciences, Prince of Wales Hospital, Hong Kong, China; Hong Kong Eye Hospital, Hong Kong, China; Hong Kong Hub of Paediatric Excellence, The Chinese Universit
Purpose: To investigate the associations of single-nucleotide polymorphisms (SNPs) for axial length (AL) and spherical equivalent (SE) with corneal biomechanical parameters in children.
Methods: A cohort of 2535 Chinese children, 4-12 years old, underwent measurements of corneal biomechanical properties, including corneal hysteresis (CH), corneal resistance factor (CRF), deformation amplitude (DA), peak distance (PD), highest concavity radius, as well as first and second applanation lengths and velocities (V1 and V2). Fifteen candidate SNPs for AL and SE were genotyped for association analyses.
Epilepsia Open
August 2025
Institute of Pharmacology, Toxicology, and Pharmacy, Ludwig-Maximilians-Universität, Munich, Germany.
Rigorous and transparent procedures in preclinical epilepsy research studies are important to permit assessing the reproducibility of their findings and derisk their translation into the clinic. The General Pharmacology Working Group of the ILAE/AES Task Force (TASK3-WG1A) developed common data elements (CDEs) addressing rigor and transparency and organized the CDEs into a case report form (CRF) to provide guidance on study planning, conduct, analysis, and reporting. CDEs specifying the type of study, use of inclusion-exclusion criteria, quantitative methods, randomization, blinding, and masking were developed and defined.
View Article and Find Full Text PDF